Vita Life Sciences Limited (ASX:VLS)

Vita Life Sciences Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	137	111	96	77	105	54
Market Cap Growth	15.60%	16.19%	25.14%	-26.95%	93.88%	45.21%
Enterprise Value	109	84	77	62	89	43
Last Close Price	2.50	1.90	1.62	1.19	1.62	0.81
PE Ratio	15.10	12.68	10.56	10.81	12.65	8.88
Forward PE	-	16.81	16.81	16.81	16.81	16.81
PS Ratio	1.60	1.40	1.31	1.15	1.84	1.16
PB Ratio	2.60	2.13	2.21	2.10	3.45	2.21
P/TBV Ratio	2.59	2.13	2.21	2.10	3.41	2.19
P/FCF Ratio	14.88	18.70	7.78	29.06	18.29	7.26
P/OCF Ratio	13.53	18.09	7.38	27.60	17.81	7.17
EV/Sales Ratio	1.28	1.06	1.06	0.93	1.57	0.93
EV/EBITDA Ratio	8.25	6.99	6.39	5.66	7.94	5.52
EV/EBIT Ratio	8.69	7.20	6.53	5.79	8.11	5.70
EV/FCF Ratio	11.92	14.10	6.29	23.57	15.58	5.79
Debt / Equity Ratio	0.04	0.01	0.01	0.02	0.01	0.09
Debt / EBITDA Ratio	0.17	0.04	0.03	0.05	0.03	0.26
Debt / FCF Ratio	0.25	0.09	0.03	0.23	0.07	0.28
Asset Turnover	1.20	1.21	1.32	1.38	1.35	1.23
Inventory Turnover	2.31	2.33	2.34	2.03	2.42	2.47
Quick Ratio	2.13	2.11	2.21	1.66	1.59	1.64
Current Ratio	2.94	3.06	2.98	2.77	2.43	2.24
Return on Equity (ROE)	18.37%	18.36%	22.74%	21.94%	30.06%	24.96%
Return on Assets (ROA)	11.03%	11.06%	13.30%	13.82%	16.32%	12.51%
Return on Invested Capital (ROIC)	34.29%	37.40%	42.75%	40.39%	60.21%	41.14%
Return on Capital Employed (ROCE)	23.10%	22.20%	27.20%	29.00%	35.80%	29.00%
Earnings Yield	6.82%	7.89%	9.47%	9.25%	7.91%	11.27%
FCF Yield	6.72%	5.35%	12.86%	3.44%	5.47%	13.78%
Dividend Yield	3.75%	5.27%	5.55%	5.05%	3.56%	5.23%
Payout Ratio	59.21%	58.85%	37.08%	42.88%	34.91%	32.38%
Buyback Yield / Dilution	-2.58%	-1.70%	-1.30%	-1.64%	-0.97%	3.93%
Total Shareholder Return	1.17%	3.57%	4.25%	3.41%	2.59%	9.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.